Inthera Bioscience Raises CHF 10.5 Million in Series A Financing Round
Zurich, Switzerland, May 31, 2017 / B3C newswire / -- Inthera Bioscience, a Swiss biopharmaceutical company developing first-in-class targeted small molecule therapies for solid tumors, today announced the closing of a Series A financing of CHF 10.5 …